Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy

20241 citationsJournal Articlehybrid Open Access

Authors

Mitchell Efros · Accumed Research Associates

Jed Kaminetsky · Manhattan Scientifics (United States)

Neil D. Sherman · Summit Medical Group (United States)

James W. Thomas · AbbVie (United States)

Abstract

A meaningful effect of 16-week TTS treatment on 24-hour average SBP among men with hypogonadism could not be ruled out based on the study's noninferiority criterion. The magnitude of mean changes observed may not be clinically meaningful regarding cardiovascular events.

Topics & Keywords

Hormonal and reproductive studies Pharmacology and Obesity Treatment Muscle metabolism and nutrition

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Endocrine Practice

Volume 30, Issue 9, pp. 847-853

DOI: 10.1016/j.eprac.2024.05.015

Field-Weighted Citation Impact: 0.37